Skip to content
Toggle main navigation
PURPOSE logo
PURPOSE logo
  • Home
  • Events
  • Opportunities
  • News & Publications
  • T90/R90 HEAL Pain Cohort Program
  • Mobile App
  • About
  • Exhibit
  • Affiliate Networks
    • Music4Pain (U24)
    • ENSEMBLE Network (U24)
    • Pain Research Forum (PRF)
    • ForceNET (U24)
    • NeuronS_MATTR (U24)
    • SPINEWORK Network (U24)
    Log in
    Request to Join

    News & Publications

    Do you have news or publications to share with the PURPOSE Network? Submit your news below.

    Submit Your News or Publication
    All
    Acquired Cognitive Impairment
    Acupuncture
    Addiction
    Ageing
    Alcohol Use / Alcohol Use Disorder (AUD)
    Analgesics
    Analgesics, Topical
    Anatomy
    Anesthesia, General
    Anesthesia, Intravenous regional
    Anesthesia, Local
    Anesthesia, Spinal
    Animal Models
    Anxiety
    Arthritis, Rheumatoid
    See all

    Results (54)

    Gelsemine attenuates neuropathic pain in a rat model of sciatic nerve chronic constriction injury

    Gelsemine attenuates neuropathic pain in a rat model of sciatic nerve chronic constriction injury

    Mol Pain. 2026 Jan-Dec;22:17448069261499174. doi: 10.1177/17448069261499174. Epub 2026 Oct 20.ABSTRACTObjective The effect of Gelsemine on neuropathic pain was investigated using a sciatic nerve (SN) chronic constriction injury (CCI) rat model.Methods Network pharmacology analysis was performed to identify potential molecular targets of Gelsemine associated with neuropathic pain, followed by molec
    October 22, 2026
    Mechanical Compression-Induced Peripheral Neuropathic Pain: From Astrocyte Mechanosensing and Phenotypic Reprogramming to CCL2-CCR2 Axis-Targeted Therapies

    Mechanical Compression-Induced Peripheral Neuropathic Pain: From Astrocyte Mechanosensing and Phenotypic Reprogramming to CCL2-CCR2 Axis-Targeted Therapies

    J Inflamm Res. 2026 Oct 14;19:634895. doi: 10.2147/JIR.S634895. eCollection 2026.ABSTRACTNeuropathic pain (NP) arising from mechanical nerve compression is driven by central sensitization, in which reactive astrocytes and chemokine-mediated neuro-glial crosstalk act as master regulators. Among candidate chemokine axes, the C-C motif chemokine ligand 2 (CCL2) and its receptor, C-C chemokine recepto
    October 20, 2026
    AT-RvD1 liposomes effectively accumulate in spinal cord and reprogram microglia via ANGPTL4-SUCLG1-propionate axis for treating neuropathic pain

    AT-RvD1 liposomes effectively accumulate in spinal cord and reprogram microglia via ANGPTL4-SUCLG1-propionate axis for treating neuropathic pain

    Mater Today Bio. 2026 Oct 5;41:103726. doi: 10.1016/j.mtbio.2026.103726. eCollection 2026 Dec.ABSTRACTNeuropathic pain (NP) remains a major clinical challenge as current medications are ineffective in treating the underlying cause, and the clinical use of these drugs also has adverse reactions such as addiction. Therefore, specialized pro-resolving mediators (SPMs) may represent a promising therap
    October 20, 2026
    Oliceridine and morphine differentially modulate the gut microbiota-intestinal barrier axis in a rat postoperative pain model

    Oliceridine and morphine differentially modulate the gut microbiota-intestinal barrier axis in a rat postoperative pain model

    Front Pharmacol. 2026 Oct 5;17:1907666. doi: 10.3389/fphar.2026.1907666. eCollection 2026.ABSTRACTBACKGROUND: Oliceridine is a novel G protein-biased μ-opioid receptor agonist with potentially improved gastrointestinal tolerability compared with conventional opioids. However, its impact on postoperative intestinal homeostasis-specifically the gut microbiota and intestinal barrier-remains poorly un
    October 20, 2026
    Nociceptin orphanin F/Q Pathways are dysregulated by stress and modulate reward responsiveness and motivated behavior across species

    Nociceptin orphanin F/Q Pathways are dysregulated by stress and modulate reward responsiveness and motivated behavior across species

    Source: Molecular psychiatryAuthors: Diego A Pizzagalli, Meghan Gallo, Michael T Treadway, Brian D Kangas, Jocelyn Breton, Michael R Bruchas, Ann M Graybiel, Emily Hueske, Kevin G Bath, Publication Date: Sat, 19 Sep 2026 06:00:00 -0400Mol Psychiatry. 2026 Sep 19. doi: 10.1038/s41380-026-03898-5. Online ahead of print.ABSTRACTNociceptin orphanin F/Q has been implicated in stress-related depressive
    October 16, 2026
    Cannabinoids for Acute Pain Management: A Contemporary Scoping Review of Evidence, Mechanisms, and Clinical Implications

    Cannabinoids for Acute Pain Management: A Contemporary Scoping Review of Evidence, Mechanisms, and Clinical Implications

    Curr Pharm Des. 2026 Oct 5. doi: 10.2174/0113816128510427260927100857. Online ahead of print.ABSTRACTBACKGROUND: The global opioid crisis has intensified interest in non-opioid and opioid-sparing analgesic strategies, including cannabinoids. Despite the expanding legal landscape for cannabis and a rapidly growing cannabinoid market, the clinical evidence for cannabinoid use in acute pain managemen
    October 13, 2026
    Multi-molecular adaptations of long-term opioid use in chronic pain

    Multi-molecular adaptations of long-term opioid use in chronic pain

    Brain. 2026 Oct 1:awag339. doi: 10.1093/brain/awag339. Online ahead of print.ABSTRACTMillions of chronic pain patients are managed with opioids, yet the neuropsychological implications of stable long-term daily opioid consumption remain unknown. Here, we contrasted the psychosocial profiles and brain structure and function of 70 chronic back pain patients prescribed opioids (CBP+O, average current
    October 1, 2026
    K2P channels as emerging therapeutic targets for pain: insights from functional studies and transcriptomic analyses

    K2P channels as emerging therapeutic targets for pain: insights from functional studies and transcriptomic analyses

    Front Pharmacol. 2026 Sep 3;17:1907761. doi: 10.3389/fphar.2026.1907761. eCollection 2026.ABSTRACTTwo-pore domain potassium (K2P) channels are major determinants of neuronal excitability through their ability to generate leak potassium currents that control resting membrane potential and action potential firing. Initially considered as passive background channels, K2P channels are now recognized a
    September 18, 2026
    Impact of CYP Enzyme Polymorphisms on Opioid Response in Anesthesia and Pain Medicine

    Impact of CYP Enzyme Polymorphisms on Opioid Response in Anesthesia and Pain Medicine

    Pain Res Manag. 2026;2026(1):e6605418. doi: 10.1155/prm/6605418.ABSTRACTOpioids serve as the cornerstone for anesthesia, postoperative analgesia, and chronic pain management. However, significant interindividual variations exist in their efficacy and safety, posing substantial challenges to clinical practice. Genetic polymorphisms of Cytochrome P450 (CYP) enzymes, particularly CYP2D6 and CYP3A4/5,
    September 7, 2026
    Intrathecal semaglutide attenuates burn injury-induced pain in mice through a spinal GLP-1R-linked enkephalin/delta-opioid receptor pathway

    Intrathecal semaglutide attenuates burn injury-induced pain in mice through a spinal GLP-1R-linked enkephalin/delta-opioid receptor pathway

    Neuropharmacology. 2026 Aug 30:111163. doi: 10.1016/j.neuropharm.2026.111163. Online ahead of print.ABSTRACTBurn injury-induced pain (BIP) is a complex condition whose spinal mechanisms remain incompletely understood. Although spinal glucagon-like peptide-1 receptor (GLP-1R) signaling has been implicated in pain modulation, its contribution to BIP remains unclear. Using a mouse model of second-deg
    August 31, 2026
    The Use of Intravenous Clonidine in Postoperative Pain Management: A Scoping Review

    The Use of Intravenous Clonidine in Postoperative Pain Management: A Scoping Review

    Acta Anaesthesiol Scand. 2026 Oct;70(9):e70329. doi: 10.1111/aas.70329.ABSTRACTBACKGROUND: Clonidine, an alpha-2 receptor agonist, has been explored as a potential analgesic in postoperative pain management, but its efficacy and safety profile remain unclear. The aim of this scoping review was to present the evidence on the use of intravenous clonidine in postoperative pain management.METHODS: Thi
    August 28, 2026
    Cyclodextrins in chronic pain: Membrane cholesterol remodeling and neuroimmune signaling

    Cyclodextrins in chronic pain: Membrane cholesterol remodeling and neuroimmune signaling

    Biomed Pharmacother. 2026 Aug 27;203:119889. doi: 10.1016/j.biopha.2026.119889. Online ahead of print.ABSTRACTBACKGROUND: Chronic pain remains challenging to treat, with current therapies offering incomplete relief and significant side effects. This narrative review examines cyclodextrins (CDs) beyond their conventional excipient role, focusing on their emerging function as membrane-active modulat
    August 28, 2026
    Antinociceptive Role of beta-alanine in Hot Plate-induced Pain in Mice

    Antinociceptive Role of beta-alanine in Hot Plate-induced Pain in Mice

    Arch Razi Inst. 2025 Nov 1;80(6):1459-1468. doi: 10.32598/ARI.80.6.3433. eCollection 2025 Nov.ABSTRACTINTRODUCTION: Pain is a distressing sensation that arises as a consequence of damage to bodily tissues, whereas β-alanine is an amino acid that is both nonessential and non-proteinogenic, functioning as an inhibitory neurotransmitter. Hence, the purpose of this investigation was to ascertain the a
    August 21, 2026
    Integrating Ketamine and Autogenic Training for Chronic Pain: A Case Study at Walter Reed National Military Medical Center

    Integrating Ketamine and Autogenic Training for Chronic Pain: A Case Study at Walter Reed National Military Medical Center

    Mil Med. 2026 Aug 20:usag396. doi: 10.1093/milmed/usag396. Online ahead of print.ABSTRACTKetamine has demonstrated efficacy in managing chronic pain and, when combined with psychotherapy, alleviating psychiatric symptoms. However, no published studies have examined the integration of ketamine infusion with autogenic training for chronic pain management. This case study evaluated the feasibility of
    August 20, 2026
    Tramadol Co-Administration with Oxycodone or Hydrocodone Increases Opioid Burden without Improving Postoperative Pain Control

    Tramadol Co-Administration with Oxycodone or Hydrocodone Increases Opioid Burden without Improving Postoperative Pain Control

    Clin Pharmacol Ther. 2026 Aug 17. doi: 10.1002/cpt.70434. Online ahead of print.ABSTRACTTramadol is frequently co-prescribed with oxycodone or hydrocodone after surgery under the assumption that its dual mechanism of action provides an opioid-sparing benefit. However, evidence supporting this practice is limited and inconsistent. We conducted a secondary analysis of the multicenter IGNITE ADOPT-PG
    August 17, 2026
    The Combination of Buprenorphine and Pregabalin in the Management of Peripheral Neuropathic Pain: A Phase IV, Randomized, Double-Blind and Placebo-Controlled Clinical Trial

    The Combination of Buprenorphine and Pregabalin in the Management of Peripheral Neuropathic Pain: A Phase IV, Randomized, Double-Blind and Placebo-Controlled Clinical Trial

    Eur J Pain. 2026 Aug;30(7):e70359. doi: 10.1002/ejp.70359.ABSTRACTBACKGROUND: Pharmacological combinations are commonly used for treating refractory neuropathic pain, although supporting evidence is lacking. Gabapentinoid-opioid combination is one of the most studied; however, their efficacy is inconsistent across clinical trials. This trial investigated the feasibility, effectiveness and safety o
    August 17, 2026
    Cannabis-Based Oil for Pain and Other Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial

    Cannabis-Based Oil for Pain and Other Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial

    Mov Disord. 2026 Aug 7. doi: 10.1002/mds.70449. Online ahead of print.ABSTRACTBACKGROUND: There is a lack of treatments for non-motor symptoms (NMS) in Parkinson's disease (PD).OBJECTIVE: To assess the safety and effectiveness of an oral Cannabis sativa L. extract on pain and other NMS of PD.METHODS: This phase II, randomized, placebo-controlled trial evaluated a formulation containing cannabidiol
    August 7, 2026
    Phase 2b Trial of a Na(V)1.8 Inhibitor for Acute Pain

    Phase 2b Trial of a Na(V)1.8 Inhibitor for Acute Pain

    N Engl J Med. 2026 Jul 30;395(5):454-464. doi: 10.1056/NEJMoa2602910.ABSTRACTBACKGROUND: Nav1.8, a voltage-gated sodium channel expressed in the peripheral nervous system, has a critical role in pain signaling. Previous trials of NaV1.8 inhibitors have shown effectiveness in reducing postoperative pain.METHODS: We conducted a phase 2b, double-blind, randomized, placebo-controlled trial to evaluate
    August 6, 2026
    Efficacy of Antidepressants in Treating Functional Abdominal Pain Disorders in Children: A Meta-Analysis of Randomized Controlled Trials

    Efficacy of Antidepressants in Treating Functional Abdominal Pain Disorders in Children: A Meta-Analysis of Randomized Controlled Trials

    Pediatr Gastroenterol Hepatol Nutr. 2026 Jul;29(4):340-348. doi: 10.5223/pghn.2026.29.4.340. Epub 2026 Jul 7.ABSTRACTPURPOSE: Functional abdominal pain disorders (FAPDs) affect 13.5% of children and are challenging to treat owing to their poor quality of life and chronicity. Although antidepressants are potential interventions, the evidence of their efficacy remains inconclusive. This study evalua
    July 23, 2026
    Kappa opioid receptors in excitatory spinal neurons gate acute pain: evidence from mouse and human

    Kappa opioid receptors in excitatory spinal neurons gate acute pain: evidence from mouse and human

    bioRxiv [Preprint]. 2026 Jul 6:2026.07.01.735618. doi: 10.64898/2026.07.01.735618.ABSTRACTThe kappa opioid receptor (KOR) has emerged as a promising, nonaddictive analgesic target, yet the neural mechanisms underlying KOR inhibition of pain are not entirely understood. Here, we provide converging evidence that KOR expressed on spinal neurons inhibits acute pain. We demonstrate that pharmacological
    July 17, 2026
    Contact
    Neurovations Education
    [email protected]

    United States

    PURPOSE@PainResearchers.com
    707-260-0848
    Links
    • NIH HEAL Initiative
    • Research in Pain Management